These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3814219)

  • 1. Sulmazole effects on mechanical performance of hypoxic and reoxygenated isolated mammalian myocardium.
    Bonoron-Adèle S; Grellet J; Bricaud H; Tariosse L; Besse P
    Arzneimittelforschung; 1986 Nov; 36(11):1572-7. PubMed ID: 3814219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation into the inotropic mechanisms of sulmazole.
    Walland A
    Arzneimittelforschung; 1985; 35(1A):369-76. PubMed ID: 4039176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of the calcium dependent myocardial contractility to the new cardiotonic agent sulmazole.
    Achenbach C; Ziskoven R; Wiemer J; Hauswirth O
    Arzneimittelforschung; 1984; 34(11):1498-506. PubMed ID: 6543125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive inotropic effects of milrinone, sulmazole and AR-L100 on isolated normal and infarcted hearts of the rat.
    Verrijk R; Vleeming W; van Rooij HH; Wemer J; Porsius AJ
    Arch Int Pharmacodyn Ther; 1989; 297():7-17. PubMed ID: 2730243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the new cardiotonic agent sulmazole on the slow inward current of sheep cardiac Purkinje fibres.
    Achenbach C; Ziskoven R; Wiemer J; Hauswirth O
    Arzneimittelforschung; 1984; 34(12):1743-9. PubMed ID: 6099128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiments with AR-L 115 BS on skinned cardiac fibers.
    Trube G; Trautwein W
    Arzneimittelforschung; 1981; 31(1a):185-8. PubMed ID: 7195217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the positive-inotropic activity of the benzimidazole derivative AR-L 115 BS in isolated guinea pig atria.
    Dahmen M; Greeff K
    Arzneimittelforschung; 1981; 31(1a):161-5. PubMed ID: 7195212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
    Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
    Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
    Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
    Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
    Schrader J
    Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle.
    Herzig JW; Feile K; Rüegg JC
    Arzneimittelforschung; 1981; 31(1a):188-91. PubMed ID: 7195218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of AR-L 115 BS on the function and oxygen consumption of isolated guinea pig atria as compared to g-strophanthin and theophylline].
    Siess M; Stieler K; Seifart HJ
    Arzneimittelforschung; 1981; 31(1a):165-70. PubMed ID: 7195213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
    Dämmgen J; Kadatz R; Diederen W
    Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic activity of different doses of sulmazole by infusion.
    Mendiola-García A; Fernández-Fernández JL; Tello-Arias A; Camacho-Rivera B
    Arzneimittelforschung; 1983; 33(11):1594-8. PubMed ID: 6686455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of AR-L 115 BS compared to caffeine].
    Lichtner R; Wierichs R; Bader H
    Arzneimittelforschung; 1981; 31(1a):193-6. PubMed ID: 6453594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle.
    Piazzesi G; Morano I; Rüegg JC
    Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of sulmazole on beating rate and cAMP levels in cultured cardiomyocytes].
    Miao CY; Gu KM
    Zhongguo Yao Li Xue Bao; 1990 May; 11(3):217-20. PubMed ID: 1965092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of the positive-inotropic action of AR-L 115 BS, a new cardiotonic drug.
    Diederen W; Weisenberger H
    Arzneimittelforschung; 1981; 31(1a):177-82. PubMed ID: 7195215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.